Pfizer ends cholesterol drug tests
- Share via
From Times Wire Reports
Pfizer Inc. said it had cut off all clinical trials and development for a cholesterol drug because of an unexpected number of deaths and cardiovascular problems in patients who used it.
The drug maker said an independent board monitoring a study for torcetrapib, a drug that raises good cholesterol, recommended that the work end. Pfizer is asking clinical investigators conducting trials to warn patients to stop taking the drug.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
